From StructYou came from “Twist grew revenue 23%. Cash fell 42%.”Back to the brief ↗Feed / TWST

Twist Bioscience Corporation

TWST

Healthcare · 100.85 +10.1% today

Follow TWSTAlerts

Jodie read · what matters now

A $48.8 million gain on a business sale was not enough to keep the latest reported period profitable.

The story is only the start. Jodie keeps watching the filing evidence, the companies connected to TWST, and whether its market group begins moving.

Revenue YoY+20.3%2025-09-30
Operating margin-36.2%+34.4 pts YoY
Latest story10-Q · Aug 3, 2026Read on Struct ↗
Disclosed connections15 verified links12 additional receipts in Pro
Organic co-movement groupMolecular Diagnostics · Early FollowerDiscovered from trading behaviour, not sector labels · Open group →

Who this business touches

The relationships behind TWST

Customers, suppliers, partners and competitors named in company filings—not inferred from headlines.

Depends on

XOMAXOMA Royalty CorporationinvesteeFull receipt with Pro →
ACETFiling-linked namepartnerFull receipt with Pro →

Depended on by

GRALGRAIL, Inc.supplierFull receipt with Pro →

Filing peers

PACBWGSRVTY

Companies whose filings use similar operating language.

You can see the shape of the network here. Pro opens 12 more links, the original filing receipts, and alerts when connected names begin moving. See Pro →

What is moving around it

Live connections

TWST is currently a Early Follower in the organic co-movement group Molecular Diagnostics. This group is discovered from market behaviour rather than assigned from an industry taxonomy. 3 filing-linked names are in the relationship map; none is currently confirmed as moving with the group.

Theme membership history

No durable theme membership has been observed for this name yet.